Yaqiang Huang
Zhongshan People's Hospital(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Prostate Cancer Diagnosis and Treatment, Renal cell carcinoma treatment, Cancer-related molecular mechanisms research
Most-Cited Works
- → MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1(2013)110 cited
- → Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer(2013)67 cited
- → Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer(2015)55 cited
- → Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer(2014)47 cited
- → Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1(2018)45 cited
- → MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer(2014)38 cited
- → miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein(2017)27 cited
- → Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence- free survival in patients with prostate cancer(2014)22 cited
- → Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL(2022)21 cited
- Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer.(2014)